A man accused of deliberately infecting seven young men with HIV lied to sexual partners that he was "clean", a court has ...
A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...
Clinical Trials Arena on MSN
Gilead’s HIV single-pill combo meets primary endpoints in pivotal trial
Gilead has become a significant name in the HIV landscape after its twice-yearly PrEP treatment Yeztugo touted 99.9% efficacy ...
The first complainant alleged he had been repeatedly raped at Mr Hall's home in 2015 after the pair met in a bar, the court ...
Primary effectiveness was measured by the number of patients with HIV-1 RNA ≥50 copies/mL at Week 48, as well as the number of patients with a change in CD4 cell count, and the proportion of patients ...
Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...
Zacks Investment Research on MSN
GILD's Investigational Regimen for HIV Treatment Meets Primary Goal
Gilead Sciences, Inc. GILD announced that its investigational single-tablet regimen (STR) of bictegravir and lenacapavir for HIV-1 Treatment met the primary endpoint in the late-stage ARTISTRY-1 study ...
The two-drug regimen dolutegravir/lamivudine is as effective as the three-drug regimen dolutegravir plus tenofovir ...
Despite the capability of antiretroviral drugs to suppress HIV to undetectable levels, some people living with the human ...
Thirty-four years ago, Magic Johnson shocked the world by announcing that he had contracted the human immunodeficiency virus ...
HEALTH and Child Care minister Douglas Mombeshora has said the National Aids Council (NAC) needs to bridge significant gaps ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback